VAS
EW icon

Vestmark Advisory Solutions’s Edwards Lifesciences EW Stock Holding History

Vestmark Advisory Solutions’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Buy
21,734
+9,446
+77% +$791K 0.02% 722
2026
Q1 		$984K Buy
12,288
+492
+4% +$40.6K 0.01% 876
2025
Q4 		$1.01M Buy
11,796
+4,268
+57% +$350K 0.01% 794
2025
Q3 		$585K Buy
7,528
+4,647
+161% +$363K 0.01% 661
2025
Q2 		$225K Sell
2,881
-2,727
-49% -$203K ﹤0.01% 740
2025
Q1 		$406K Buy
5,608
+2,860
+104% +$205K 0.01% 553
2024
Q4 		$203K Sell
2,748
-656
-19% -$45.9K 0.01% 559
2024
Q3 		$225K Sell
3,404
-2,854
-46% -$207K 0.01% 511
2024
Q2 		$578K Sell
6,258
-828
-12% -$73.3K 0.02% 380
2024
Q1 		$677K Buy
7,086
+252
+4% +$21.2K 0.03% 353
2023
Q4 		$521K Buy
6,834
+793
+13% +$55.2K 0.03% 341
2023
Q3 		$419K Sell
6,041
-6,932
-53% -$557K 0.03% 309
2023
Q2 		$1.22M Buy
12,973
+1,781
+16% +$155K 0.05% 408
2023
Q1 		$926K Sell
11,192
-560
-5% -$44K 0.04% 455
2022
Q4 		$877K Sell
11,752
-20
-0.2% -$1.54K 0.04% 453
2022
Q3 		$973K Sell
11,772
-5,324
-31% -$512K 0.05% 391
2022
Q2 		$1.63M Buy
17,096
+3,049
+22% +$316K 0.09% 279
2022
Q1 		$1.65M Buy
14,047
+571
+4% +$64.1K 0.09% 274
2021
Q4 		$1.75M Buy
13,476
+731
+6% +$85.3K 0.1% 255
2021
Q3 		$1.44M Buy
12,745
+20
+0.2% +$2.28K 0.1% 267
2021
Q2 		$1.32M Buy
12,725
+423
+3% +$39.9K 0.09% 272
2021
Q1 		$1.03M Buy
12,302
+6,031
+96% +$510K 0.09% 281
2020
Q4 		$572K Buy
6,271
+2
+0% +$166 0.06% 326
2020
Q3 		$500K Sell
6,269
-448
-7% -$35K 0.07% 323
2020
Q2 		$464K Buy
6,717
+636
+10% +$45.2K 0.07% 318
2020
Q1 		$382K Buy
+6,081
New +$439K 0.07% 311
2019
Q4 		– Sell
-6,126
Closed -$449K – 338
2019
Q3 		$449K Sell
6,126
-795
-11% -$55.8K 0.07% 319
2019
Q2 		$426K Sell
6,921
-867
-11% -$52.4K 0.07% 316
2019
Q1 		$497K Buy
+7,788
New +$444K 0.09% 283

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Vestmark Advisory Solutions's EW Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its Edwards Lifesciences (EW) stake by 77% in Q2 2026, buying an estimated $791K and bringing the position to 21,734 shares worth $1.97M. The position accounts for 0.02% of the portfolio, ranked #722.

Vestmark Advisory Solutions first reported a position in EW in Q1 2019 and has held it in 29 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Vestmark Advisory Solutions held 21,734 shares of Edwards Lifesciences worth $1.97M as of Q2 2026.
  • Vestmark Advisory Solutions bought 9,446 Edwards Lifesciences shares in Q2 2026, an estimated $791K.
  • Edwards Lifesciences made up 0.02% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #722 holding.
  • Vestmark Advisory Solutions first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 29 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.